Daniel is a biotechnology scientist with 10 years’ experience working in the field of pharmaceutical biotech including various translational aspects of drug development and production. As a post-doctoral fellow at the Lausanne University Hospital (CHUV) Daniel worked on methods for therapeutic gene delivery and modulation using different modalities including antisense oligonucleotides. During his PhD at the University of Lausanne and Ecole Polytechnique Fédérale de Lausanne (EPFL), his work was focused on the development of novel strategies for manufacturing processes in compliance with GMP standards in support of different gene therapy applications and clinical trials.
